Correspondence 0001903596-23-000118 from Iremedy Healthcare Companies, Inc. (CIK 0001691249)
Iremedy Healthcare Companies, Inc. (CIK 0001691249)
Date: Feb. 9, 2023 · CIK: 0001691249 · Accession: 0001903596-23-000118
AI Filing Summary & Sentiment
File numbers found in text: 024-12009
Letter
Office of Trade & Services Division of Corporation Finance Securities and Exchange Commission File No. 024-12009 Acceleration Request Requested Date: February 13, 2023 Requested Time: 4:00 pm Eastern Time
Dear Sir or Madam:
The iRemedy Healthcare Companies, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Offering Statement on Form 1-A qualified at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Craig D. Linder, who is an attorney with the Company’s outside legal counsel, Anthony L.G., PLLC, to orally modify or withdraw this request for acceleration.
The Company hereby acknowledges that:
● should the Commission or the staff of the Commission, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing qualified, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● the Company may not assert the staff comments and the declaration of qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The Company also agrees that it will only sell shares of its common stock pursuant to the subject Offering Statement in states where the offering is registered or where there is an applicable exemption from the applicable state’s securities law available.
The Company requests that it be notified of such qualification by a telephone call to Craig D. Linder, Esq. at (561) 514-0936 or email to him at: clinder@anthonypllc.com.
Very truly yours,
The
iRemedy Healthcare Companies, Inc.
Show Raw Text
CORRESP
1
filename1.htm
The
iRemedy Healthcare Companies, Inc.
7118
South Kanner Highway
Stuart,
Florida 34997
(407)
395-4283
February
9, 2023
Office
of Trade & Services
Division
of Corporation Finance
Securities
and Exchange Commission
100
F. Street, N.E.
Washington,
D.C. 20549
Re:
The
iRemedy Healthcare Companies, Inc.
Offering
Statement on Form 1-A
Filed
on September 29, 2022
File
No. 024-12009
Acceleration
Request
Requested
Date: February 13, 2023
Requested
Time: 4:00 pm Eastern Time
Dear
Sir or Madam:
The
iRemedy Healthcare Companies, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”)
take appropriate action to declare the above-captioned Offering Statement on Form 1-A qualified at the “Requested Date” and
“Requested Time” set forth above or as soon thereafter as practicable.
The
Company hereby authorizes Craig D. Linder, who is an attorney with the Company’s outside legal counsel, Anthony L.G., PLLC, to
orally modify or withdraw this request for acceleration.
The
Company hereby acknowledges that:
●
should the Commission or the staff of the Commission,
acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action
with respect to the filing;
●
the action of the Commission or the staff, acting pursuant
to delegated authority, in declaring the filing qualified, does not relieve the Company from its full responsibility for the adequacy
and accuracy of the disclosure in the filing; and
●
the Company may not assert the staff comments and the
declaration of qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States.
The
Company also agrees that it will only sell shares of its common stock pursuant to the subject Offering Statement in states where the
offering is registered or where there is an applicable exemption from the applicable state’s securities law available.
The
Company requests that it be notified of such qualification by a telephone call to Craig D. Linder, Esq. at (561) 514-0936 or email to
him at: clinder@anthonypllc.com.
Very truly yours,
The
iRemedy Healthcare Companies, Inc.
By:
/s/ Anthony
Paquin
Anthony Paquin
Chief Executive Officer